{
    "address": "",
    "city": "COPENHAGEN",
    "country": "DK",
    "currency": "DKK",
    "cusip": "K3R52P104",
    "description": "FluoGuide A/S engages in the development of surgical solutions to reduce suffering for the patient and increase the likelihood of cure; as well as reducing costs for the health care system. The firm develops surgical solutions, which expected to reduce Cancer pain for the patient and increases the possibility of recovering as well as reducing costs for the health care system. The first product is the compound FG001, which lights up the cancer and its invasive growth into the surrounding tissue.",
    "employeeTotal": "",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Biotechnology",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Biotechnology",
    "gsector": "Health Care",
    "gsubind": "Biotechnology",
    "ipo": "2019-05-07",
    "isin": "DK0061123312",
    "logo": "",
    "marketCapitalization": 1032.852,
    "naics": "Scientific Research and Development Services",
    "naicsNationalIndustry": "Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)",
    "naicsSector": "Professional, Scientific, and Technical Services",
    "naicsSubsector": "Professional, Scientific, and Technical Services",
    "name": "Fluoguide AS",
    "phone": "4531226660.0",
    "sedol": "BJLT042",
    "shareOutstanding": 10.530026,
    "state": "",
    "ticker": "FLUO.ST",
    "weburl": ""
}